(Q83818621)

English

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient

scientific article published on 08 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

based on heuristic

inferred from title

tumor progression

1 reference

based on heuristic

inferred from title

2

object named as

Hitoshi Tsuda

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

4

object named as

Masashi Takano

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Osamu Matsubara

6

object named as

Osamu Matsubara

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Sohei Yamamoto

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Kosuke Miyai

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Seiichi Tamai

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

publication date

8 April 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Modern Pathology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1146-1155

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21478826%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

https://scigraph.springernature.com/pub.10.1038/modpathol.2011.70

0 references

Histological classification of ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

c-Met: structure, functions and potential for therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the c-Met signaling pathway in cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Met, metastasis, motility and more

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas*

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel mutations of the MET proto-oncogene in papillary renal carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of c-met expression in ovarian epithelial tumors and normal epithelia of the female reproductive tract by quantitative laser scan microscopy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

HGF/MET signaling in ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybrid

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an ind

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

The PI3K-Akt mediates oncogenic Met-induced centrosome amplification and chromosome instability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.70

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83818621&oldid=2070805796"